Delivery Order SPE2DB22D6029-SPE2DB25FLVTA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veozah 45 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract ceiling value is $6,509.38, with an ultimate completion date of July 31, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,038.28 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction under a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,872.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $3,479.11. This non-set-aside delivery order is scheduled for completion by August 1, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,292.12 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Veozah 45 mg tablets (30-count) under a firm fixed-price contract valued at $13,694.27. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) under a firm fixed-price contract valued at $7,199.04. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside contract represents a single delivery order for pharmaceutical product fulfillment, with performance to be completed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $12,719.67 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VEOZAH 45 mg tablets in 30-count packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVTADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count package) valued at $1,532.04. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. The IDC serves as the primary vehicle through which AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems globally. AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, combined with its demonstrated capability to meet competitive federal requirements, positions the company to fulfill the specialized medication needs of the Defense Health Agency and other government healthcare customers through this delivery mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/19/25 |